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Abstract 22 
Objectives 23 
Antibiotics are used for various reasons before elective joint replacement surgery. The aim of this 24 
study was to investigate patients’ use of oral antibiotics before joint replacement surgery and how 25 
this affects the risk for periprosthetic joint infection (PJI). 26 
Methods 27 
Patients having a primary hip or knee replacement in a tertiary care hospital between September 28 
2002 and December 2013 were identified (n=23 171). Information on oral antibiotic courses 29 
purchased 90 days preoperatively and patients’ chronic diseases was gathered. Patients with a PJI in 30 
a one-year follow-up period were identified. The association between antibiotic use and PJI was 31 
examined using a multivariable logistic regression model that included other factors possibly 32 
associated with the risk of infection. 33 
Results 34 
158 (0.68%) cases of PJI were identified. 4 106 (18%) joint replacement operations were preceded by 35 
at least one course of antibiotics. The incidence of PJI for patients with preoperative use of oral 36 
antibiotics was 0.29% (12/4 106), whereas for patients without antibiotic use it was 0.77% (146/19 37 
065). A preoperative antibiotic course was associated with a reduced risk for subsequent PJI in the 38 
univariate (OR 0.38, 95% CI 0.21 – 0.69) and multivariable model (OR 0.40, 95% CI 0.22–0.73). 39 
Conclusions 40 
The use of oral antibiotics before elective joint replacement surgery is common and has a potential 41 
effect on the subsequent risk for PJI. Nevertheless, indiscriminate use of antibiotics before elective 42 
joint replacement surgery cannot be recommended, even though treatment of active infections 43 
remains an important way to prevent surgical site infections. 44 
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Introduction 45 
Periprosthetic joint infection (PJI) is a catastrophic complication of joint replacement surgery (1). 46 
Therefore, it is essential that adequate preventive measures are taken before any elective joint 47 
replacement operation. 48 
Active infections, including skin and urinary tract infections, at the time of operation are considered 49 
as potential risk factors for subsequent surgical site infection (SSI). Their treatment has been 50 
recommended by the international consensus statement on PJIs (2). Furthermore, active 51 
preoperative screening and treatment of dental infections is recommended (2-4). 52 
Staphylococcal skin and nasal colonization is common among patients before elective joint 53 
replacement (5,6). Thus, even without the presence of active infection, preoperative decolonization 54 
may reduce the incidence of SSIs caused by Staphylococcus aureus (6-9). The use of oral antibiotics 55 
can reduce carriage of S.aureus (10), but it has been suggested that oral antibiotics may not reach 56 
sufficient nasal concentrations for effective decolonization. Therefore, they are recommended for 57 
decolonization of methicillin-resistant S.aureus (MRSA) only in conjunction with topical agents 58 
(11,12). 59 
Although perioperative intravenous antibiotics have a well-established role in the prevention of SSIs 60 
related to joint replacement surgery (13,14), no studies have been conducted on the use of 61 
preoperative oral antibiotic before joint replacement surgery and its effect on the risk for subsequent 62 
SSI or PJI. The aim of this study was to investigate patients’ use of preoperative antibiotics and how 63 
this affects the risk for PJI in a one-year follow-up. 64 
Methods 65 
This retrospective study was performed in the Coxa Hospital for Joint Replacement, Tampere, 66 
Finland. Patients, who had undergone an elective primary hip or knee replacement between 67 
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September 2002 and December 2013, were identified from the local prospective joint replacement 68 
database. Patient consent is not required in retrospective studies like this, according to the Finnish 69 
national legislation. If more than one primary joint replacement was performed on a patient during 70 
the study period, each operation was considered separately. During the years 2002–2007 patients 71 
considered to have high risk for MRSA carriage were screened for MRSA. From 2008 onwards all 72 
patients were screened for MRSA on admission, but not for methicillin-sensitive S.aureus (15). 73 
Routine preoperative skin and nasal decolonization was not in use during the study period. All 74 
patients had a preoperative visit to the operating hospital within two months before the joint 75 
replacement operation, this included routine laboratory tests and a clinical check-up. Preoperative 76 
urine samples were routinely taken and 25% of the patients with bacteriuria received antibiotics (16). 77 
A single dose of cefuroxime was used as perioperative antibiotic prophylaxis. If this was 78 
contraindicated, clindamycin or vancomycin was used. Known MRSA-carriers received cefuroxime 79 
and vancomycin. Cemented prostheses were fixed with gentamicin-impregnated bone cement. 80 
The courses of antibiotics (identified based on their ATC codes (17), see web-only Supplementary 81 
Table S1) purchased by the patients within 90 days before the joint replacement were identified from 82 
the prescription register of the Social Insurance Institution of Finland. The type of antibiotic and the 83 
date of purchase were recorded. Antibiotics are not available without a prescription in Finland and all 84 
purchases are recorded in this nationwide prescription register. Antibiotics given for in-patients 85 
could not be identified. 86 
Patients with a valid entitlement to reimbursement for certain chronic diseases (diabetes, rheumatic 87 
diseases, hypertension, chronic heart failure, chronic coronary disease, arrhythmias, chronic lung 88 
disease, Parkinson’s disease, epilepsy, Alzheimer’s disease, psychotic disorders, haematological and 89 
solid malignancies) at the time of the joint replacement were identified from the reimbursement 90 
register of the Social Insurance Institution of Finland (see a more detailed description in a previous 91 
study of the same study population (16)). For the analyses, chronic heart failure, chronic coronary 92 
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disease and arrhythmias were grouped together, as were Parkinson’s disease, epilepsy, Alzheimer’s 93 
disease and psychotic disorders. 94 
The weight and height of patients were retrieved from the local prospective joint replacement 95 
database to calculate body mass indexes (BMIs). The data on the types of prostheses, municipality of 96 
residence and indication of surgery was also gathered from the database. MRSA carriers were 97 
identified from the official database of carriers of multidrug resistant microbes in Pirkanmaa Health 98 
District. 99 
Cases of infection were identified from prospective post-discharge surveillance data gathered by an 100 
infection control nurse according to the Centers for Disease Control and Prevention criteria (18) and 101 
National Nosocomial Infection Surveillance system methodology adapted for Finland (19). The 102 
primary outcome was the occurrence of PJI. The occurrence of any surgical site infection (superficial 103 
or deep incisional infection or PJI) was considered as a secondary outcome. Infection cases recorded 104 
between September 2002 and December 2014 were identified in order to have a 1-year follow up 105 
period for all operated joints. Microbiological data on the pathogens causing PJIs were collected from 106 
the electronic records of the microbiology laboratory.  107 
Statistical analysis 108 
All data analyses and management were performed using SPSS for Windows 23.0 statistical software 109 
package. 110 
Categorical variables were compared with χ2 test and continuous variables (age) with Student’s 111 
independent-samples t-test. P-value <0.05 was considered statistically significant. 112 
The association between preoperative antibiotic use and the outcome (PJIs and all infections 113 
separately) was examined using logistic regression with univariate analysis, and odds ratios and 95% 114 
confidence intervals (CI) were calculated. Then, a multivariable model was developed in order to 115 
consider possible confounding factors.Patients’ gender, operated joint, age, BMI, use of cement in 116 
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the operation, indication for surgery (arthrosis, rheumatic disease, previous trauma and other 117 
reasons) and chronic diseases (chronic heart disease, chronic lung disease, diabetes, hypertension, 118 
malignancy, neurological or psychiatric disorder and rheumatic disease) were all included in the 119 
model. Patients with the use of antibiotics with potential activity against staphylococcal species (i.e. 120 
amoxicillin-clavulanate, cephalosporins, clindamycin, flucloxacillin, fluoroquinolones, macrolides, 121 
tetracyclines, trimethoprim and trimethoprim/sulfamethoxazole) (20) were examined separately. 122 
Results 123 
In total, there were 23 171 primary joint replacements performed for 17 562 patients. Table 1 shows 124 
the general characteristics of the study population. During the one-year follow-up, 158 PJIs occurred 125 
in the study population (incidence 0.68%). Overall, 490 surgical site infections (2.11% of the study 126 
population) were identified. 127 
4 106 (18%) of the joint replacement operations were preceded by one or more courses of oral 128 
antibiotics within 90 days before the operation. In 989 (4.3% of the study population) cases there 129 
were two or more antibiotic courses. The distribution of the time difference between the joint 130 
replacement surgery and the date of purchase of the antibiotic course closest to the operation is 131 
shown in Figure 1. The median number of days between the joint replacement and the antibiotic 132 
course was 30. The most commonly used antibiotics were first generation cephalosporins, penicillin 133 
and pivmecillinam (Table 2). In total, there were 5 741 packages of antibiotics purchased 134 
preoperatively, giving an antibiotic consumption of 2.75 packages per 1000 patients per day. 135 
The incidence of PJI for patients with preoperative oral antibiotic use was 0.29% (12/4 106), whereas 136 
for patients without antibiotics the incidence was 0.77% (146/19 065). A preoperative oral antibiotic 137 
course was associated with a decreased risk for subsequent PJI (OR 0.38, 95% CI 0.21–0.69). After 
138 
adjusting for potential confounding factors in the multivariable model, the risk for PJI for patients 139 
with preoperative antibiotic use was still statistically significantly lower (OR 0.40, 95% CI 0.22–0.73). 140 
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The results were similar when antibiotic use within 30 days was considered: the incidence of PJI was 141 
0.19% (4/2 066) for patients with antibiotic use and 0.73% (154/21 105)  for patients without 142 
antibiotics (OR 0.26, 95% CI 0.10–0.71, in the univariate and OR 0.24, 95% CI 0.08–0.77, in the 143 
multivariable analysis) . 144 
Of the twelve cases of PJI with preoperative oral antibiotic use, six were classified as early infections, 145 
occurring within 30 days from the joint replacement. Overall, 34% (54/158) of the PJIs were early 146 
infections. The causative organism for the PJI with preoperative oral antibiotic use could be identified 147 
in five cases: in two cases it was Staphylococcus aureus, in two cases a coagulase-negative 148 
staphylococcus and one case was polymicrobial (a coagulase-negative staphylococcus and 149 
Enterococcus faecalis) (see Supplementary Table S2). The remaining cases (7/12, 58%) were culture-150 
negative. On the other hand, 16% (23/146) of the PJIs in patients without antibiotic use were culture-151 
negative. 152 
When also superficial infection cases were included in the analysis, preoperative antibiotic use did 153 
not have an effect on the overall risk for surgical site infection: the incidence was 1.90% (78/4 106) 154 
for patients with antibiotic use and 2.16% (412/19 065) for patients without antibiotic use (OR 0.88, 155 
95% CI 0.69–1.12). 156 
No single antibiotic agent or antibiotic group reduced the risk for PJI statistically significantly (Table 157 
2). However, when compared with patients without the use of pre-operative oral antibiotics, the risk 158 
for PJI was lower for patients with anti-staphylococcal antibiotics (OR 0.34, 95% CI 0.16–0.72), but 159 
not for patients with the use of other antibiotics (OR 0.46, 95% CI 0.19–1.13). 160 
A lower incidence of PJI for patients with antibiotic use was observed also when the analyses were 161 
repeated in the subgroups of hip and knee joint replacements (separately), operations with and 162 
without the use of cement, patients with osteoarthritis as the indication for surgery and the year 163 
when the surgery was conducted (see Supplementary Table S3). Statistically significant differences, 164 
however, were not observed in all cases due to insufficient statistical power. 165 
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Discussion 166 
This large study shows that the use of oral antibiotics before elective joint replacement surgery is 167 
common. Also, the use of antibiotics preoperatively is associated with and may have an effect on the 168 
subsequent risk for periprosthetic joint infection. 169 
In this study population, almost one fifth of the patients with elective joint replacement had received 170 
oral antibiotics within three months before surgery. The use of oral antibiotics prior to joint 171 
replacement surgery has hardly been studied. In a Swedish study by Stefansdottir et al. (5), 25% of 172 
the patients coming for elective joint replacement had received antibiotics within six months before 173 
surgery, a number comparable to the present study. This study indicates that patients with elective 174 
joint replacement seem to receive more antibiotics than the general population. According to the 175 
data published by European Centre for Disease Prevention and Control, the overall antibiotic 176 
consumption in Finland has been about 2 packages per 1000 inhabitants per day in the recent years 177 
(21), whereas in this study the number was 2.75 packages per 1000 patients per day. 178 
The incidence of PJI was lower among patients with preoperative oral antibiotic use than among 179 
patients without antibiotic use. The effect of oral antibiotic use on the risk for PJI has not been 180 
studied before and thus this finding has not been reported previously. Treatment of active infections 181 
before joint replacement surgery is recommended in the international consensus statement on PJIs 182 
(2), because there is a risk for haematogenous spread to the replaced joint postoperatively from non-183 
treated infection sites. However, treatment of active infections should decrease the risk for PJI to the 184 
level of the general population, but not offer any additional prophylactic protection. Furthermore, 185 
active infections would probably lead to delaying the surgery. 186 
Preoperative oral antibiotic use could possibly reduce the frequency of Staphylococcus aureus 187 
carriage. Supporting this view, the current study indicates that especially the use of staphylococcal 188 
antibiotics seemed to reduce the incidence for PJI. It has been estimated that 25% to 40% of the 189 
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population are nasal carriers of Staphylococcus aureus (6,10), and similar numbers have been found 190 
among patients with joint replacement surgery (5,8). In addition, nasal carriage of S.aureus is 191 
recognized as an independent risk factor for subsequent surgical site infection after joint 192 
replacement surgery (22) and different pre-operative decolonization regimens have been proposed. 193 
These include nasal mupirocin ointment with or without skin decolonization (6). In a systematic 194 
review Chen et al. found that surgical site infection rates could be reduced by 13% to 200% with 195 
decolonization-programmes (8). However, most of the studies included in the review involved only 196 
patients, who screened positive for S.aureus. On the other hand, Sousa et al. found in a small 197 
randomized controlled trial that decolonization was not effective in reducing the rate of PJI (23), and 198 
the international consensus statement on PJIs does not recommend universal screening and 199 
decolonization of patients undergoing joint replacement surgery (2). Unfortunately, there is no 200 
information on the rate of S.aureus carriage in the present study population and therefore the effect 201 
of the use of oral antibiotics on the risk of PJI in relation to the carriage rate could not be examined. 202 
On the other hand, it has been proposed that oral antibiotics may not reach sufficient concentrations 203 
in the nares for adequate decolonization (12). Nevertheless, studies on MRSA colonization have 204 
shown that carriage of S.aureus outside the nasopharynx is also common (24,25), even though the 205 
role of oral antibiotics in reducing carriage in non-nasal sites is unclear. Furthermore, it is unclear for 206 
how long the potential effect of oral antibiotics in S.aureus decolonization could last. In a study 207 
conducted among children with skin infections and colonized by S.aureus, oral antibiotics reduced 208 
the carriage rate by half and this effect could be seen up to 50 days after the course of antibiotics 209 
(26). 210 
Another possible mechanism for action for the antibiotics could be that the patients had “hidden” 211 
infections that were treated, but this seems unlikely, and for example treating bacteriuria with 212 
antibiotics has been shown to be ineffective in the prevention of PJI in the same study population 213 
(16). 214 
10 
There are some limitations to this study. Firstly, the indications for the antibiotics were not known, 215 
nor who had prescribed the antibiotics. The dosage of the antibiotics was also not registered, and 216 
thus antibiotic consumption rates based on defined daily doses could not be evaluated, but 217 
information on the number of pills purchased was available. Nevertheless, as all antibiotic purchases 218 
are recorded in the national register, patients’ use of antibiotics could be evaluated 219 
comprehensively. Secondly, antibiotics given in hospitals could not be identified. However, it can be 220 
assumed that this number is fairly low, since the joint replacement surgery would have been most 221 
likely postponed if the patient had required treatment for an infection in a hospital setting. Thirdly, 222 
there could be a so-called “healthy patient bias”, where healthier patients are more prone to take 223 
care of themselves and perhaps seek medical attention more readily, thus potentially receiving 224 
antibiotics more easily than others. However, the characteristics and distribution of chronic diseases 225 
of patients with and without antibiotic use were similar, and the effect of chronic diseases could be 226 
considered extensively. Finally, it is possible that the association between oral antibiotic use and 227 
lower risk for PJI could be caused by some unknown confounding factors that could not be identified 228 
in the analysis. Nevertheless, the effect of many known risk factors for PJI could be taken into 229 
account. 230 
While this study indicates that preoperative antibiotic use is associated with a lower rate of PJI, even 231 
when several confounding factors were considered and subgroup analyses performed, the use of oral 232 
antibiotics as prophylaxis cannot be recommended, unless there are active infections, due to 233 
potential harms, such as the increased risk for Clostridioides difficile infections. Furthermore, there is 234 
a risk for an increase in the incidence of resistant bacterial strains. For example, Cheng et al. have 235 
shown that the use of non-MRSA antibiotics increases the rate of nasal MRSA carriage (27). In 236 
addition, even if used, the current study shows that the number needed to treat (NNT) with 237 
preoperative oral antibiotics to prevent one case of PJI would be high (NNT 211). 238 
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In conclusion, the use of oral antibiotics before elective joint replacement surgery is common and it 239 
may affect the subsequent risk for PJI, perhaps due to a reduced rate of S.aureus carriage. Further 240 
studies are needed in order to evaluate the significance of this novel result. Meanwhile, 241 
indiscriminate use of antibiotics before elective joint replacement surgery cannot be recommended, 242 
even though the treatment of active infections remains important in the prevention of surgical site 243 
infections. 244 
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Table 1. Characteristics of patients with and without preoperative oral antibiotic use 
Patient characteristic Patients with antibiotic 
use (n= 4 106) 
Patients without 
antibiotic use (n= 
19 065) 
n % n % 
Male gender 1 324 32 7 486 39 
Age, y, mean (SD) 66 (11) 67 (11) 
Knee location 2 383 58 10 588 56 
BMI, mean (SD) 29.7 (5.3) 29.2 (5.1) 
Known MRSA-carrier 16 0.4 46 0.2 
Rural living location 493 12 2 649 14 
Chronic diseases 
Chronic heart disease a 1 577 38 6 241 33 
Chronic lung disease 375 9 1 140 6 
Diabetes 414 10 1 463 8 
Hypertension 1 285 31 5 031 26 
Malignancy 182 4 625 3 
Neurological or psychiatric disorder b 180 4 687 4 
Rheumatic disease 264 6 948 5 
Osteoarthrosis as the indication for 
operation 
3 740 91 17 265 91 
Use of cement in the operation 3 123 76 14 287 75 
a. Includes chronic heart failure, chronic coronary disease and arrhythmias 325 
b. Includes Parkinson’s disease, epilepsy, Alzheimer’s disease and psychotic disorders326 
327 
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328 
Table 2. The numbers of primary joint replacement operations preceded by different groups of 
antibiotics 90 days before surgery and their effect on the risk for periprosthetic joint infection (PJI) 
Antibiotic group Number of operations 
preceded by antibiotic use 
Effect of antibiotic on the risk for 
PJI in the univariate analysis 
n % of all 
operations 
OR 95% CI 
1st generation 
cephalosporins 
984 4.2 0.29 0.07–1.16 
Penicillin 693 3.0 0.41 0.10–1.67 
Pivmecillinam 571 2.5 0.51 0.13–2.05 
Amoxicillin 544 2.3 0.53 0.13–2.15 
Fluoroquinolones 500 2.2 0.58 0.14–2.35 
Tetracyclines 424 1.8 NAa NA 
Macrolides 374 1.6 0.78 0.19–3.16 
Trimethoprim 303 1.3 NAa NA 
Amoxicillin-clavulanate 182 0.8 NAa NA 
Clindamycin 146 0.6 1.01 0.14–7.23 
a. There were no PJIs in this group329 
330 
 
 
Fig. 1.  The time difference (in days) between the joint replacement surgery and the 
date of purchase of the antibiotic course received closest to the surgery. 
 
